These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22208674)

  • 1. Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed.
    Leonard G; Lafrenaye S; Goffaux P
    Curr Med Res Opin; 2012 Feb; 28(2):245-8. PubMed ID: 22208674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placebo response in clinical trials-the current state of play.
    Enck P; Klosterhalfen S
    Complement Ther Med; 2013 Apr; 21(2):98-101. PubMed ID: 23497810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The placebo effect revisited: lessons learned to date.
    Kirsch I
    Complement Ther Med; 2013 Apr; 21(2):102-4. PubMed ID: 23497811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcranial magnetic stimulation in treatment of depression--question of placebo and warranting of blind conditions, as well as other methodological problems].
    Zyss T
    Psychiatr Pol; 2011; 45(1):117-34. PubMed ID: 21614837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo: new insights into an old enigma.
    Ernst E
    Drug Discov Today; 2007 May; 12(9-10):413-8. PubMed ID: 17467578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo--efficacy and adverse effects in controlled clinical trials.
    Weihrauch TR; Gauler TC
    Arzneimittelforschung; 1999 May; 49(5):385-93. PubMed ID: 10367099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
    Dawson R; Lavori PW
    Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterinary clinical research database for homeopathy: placebo-controlled trials.
    Clausen J; Albrecht H; Mathie RT
    Complement Ther Med; 2013 Apr; 21(2):115-20. PubMed ID: 23497815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The placebo revisited: what we do, don't and maybe won't know.
    van Haselen R
    Complement Ther Med; 2013 Apr; 21(2):83-4. PubMed ID: 23497807
    [No Abstract]   [Full Text] [Related]  

  • 12. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A; Goldsmith C
    Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract]   [Full Text] [Related]  

  • 13. Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.
    Liu Q; Lim P; Singh J; Lewin D; Schwab B; Kent J
    J Biopharm Stat; 2012; 22(4):737-57. PubMed ID: 22651112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor regarding White et al., "The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial" (Pain 106: 401-409).
    Ernst E
    Pain; 2004 May; 109(1-2):197-8; author reply 197-9. PubMed ID: 15082144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Headache: the placebo effects in the control groups in randomized clinical trials; an analysis of systematic reviews.
    de Groot FM; Voogt-Bode A; Passchier J; Berger MY; Koes BW; Verhagen AP
    J Manipulative Physiol Ther; 2011 Jun; 34(5):297-305. PubMed ID: 21640253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials.
    Wampold BE; Minami T; Tierney SC; Baskin TW; Bhati KS
    J Clin Psychol; 2005 Jul; 61(7):835-54. PubMed ID: 15827993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
    Zhao Y; Traboulsee A; Petkau AJ; Li D
    Neurology; 2008 Mar; 70(13 Pt 2):1092-7. PubMed ID: 18003938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABC of non-inferiority margin setting from indirect comparisons.
    Julious SA
    Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial designs and exploration of the placebo response.
    Dieppe P
    Complement Ther Med; 2013 Apr; 21(2):105-8. PubMed ID: 23497812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.